nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—Gastrointestinal pain—Vandetanib—thyroid cancer	0.00252	0.00252	CcSEcCtD
Letrozole—Dysgeusia—Sorafenib—thyroid cancer	0.0025	0.0025	CcSEcCtD
Letrozole—Breast pain—Epirubicin—thyroid cancer	0.00247	0.00247	CcSEcCtD
Letrozole—Cardiovascular disorder—Epirubicin—thyroid cancer	0.00245	0.00245	CcSEcCtD
Letrozole—Body temperature increased—Vandetanib—thyroid cancer	0.00244	0.00244	CcSEcCtD
Letrozole—Abdominal pain—Vandetanib—thyroid cancer	0.00244	0.00244	CcSEcCtD
Letrozole—Bone disorder—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Letrozole—Viral infection—Epirubicin—thyroid cancer	0.00239	0.00239	CcSEcCtD
Letrozole—Neoplasm malignant—Doxorubicin—thyroid cancer	0.00234	0.00234	CcSEcCtD
Letrozole—Angioedema—Sorafenib—thyroid cancer	0.00233	0.00233	CcSEcCtD
Letrozole—Breast pain—Doxorubicin—thyroid cancer	0.00229	0.00229	CcSEcCtD
Letrozole—Leukopenia—Sorafenib—thyroid cancer	0.00228	0.00228	CcSEcCtD
Letrozole—Cardiovascular disorder—Doxorubicin—thyroid cancer	0.00227	0.00227	CcSEcCtD
Letrozole—Bone pain—Epirubicin—thyroid cancer	0.00225	0.00225	CcSEcCtD
Letrozole—Cough—Sorafenib—thyroid cancer	0.00223	0.00223	CcSEcCtD
Letrozole—Asthenia—Vandetanib—thyroid cancer	0.00221	0.00221	CcSEcCtD
Letrozole—Bone disorder—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Letrozole—Viral infection—Doxorubicin—thyroid cancer	0.00221	0.00221	CcSEcCtD
Letrozole—Hypertension—Sorafenib—thyroid cancer	0.0022	0.0022	CcSEcCtD
Letrozole—Pruritus—Vandetanib—thyroid cancer	0.00218	0.00218	CcSEcCtD
Letrozole—Musculoskeletal pain—Epirubicin—thyroid cancer	0.00218	0.00218	CcSEcCtD
Letrozole—Myalgia—Sorafenib—thyroid cancer	0.00217	0.00217	CcSEcCtD
Letrozole—Arthralgia—Sorafenib—thyroid cancer	0.00217	0.00217	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Sorafenib—thyroid cancer	0.00216	0.00216	CcSEcCtD
Letrozole—Pulmonary embolism—Epirubicin—thyroid cancer	0.00216	0.00216	CcSEcCtD
Letrozole—Dry mouth—Sorafenib—thyroid cancer	0.00212	0.00212	CcSEcCtD
Letrozole—Diarrhoea—Vandetanib—thyroid cancer	0.00211	0.00211	CcSEcCtD
Letrozole—Bone pain—Doxorubicin—thyroid cancer	0.00208	0.00208	CcSEcCtD
Letrozole—Anaphylactic shock—Sorafenib—thyroid cancer	0.00208	0.00208	CcSEcCtD
Letrozole—Infection—Sorafenib—thyroid cancer	0.00207	0.00207	CcSEcCtD
Letrozole—Nervous system disorder—Sorafenib—thyroid cancer	0.00204	0.00204	CcSEcCtD
Letrozole—Dizziness—Vandetanib—thyroid cancer	0.00204	0.00204	CcSEcCtD
Letrozole—Skin disorder—Sorafenib—thyroid cancer	0.00202	0.00202	CcSEcCtD
Letrozole—Musculoskeletal pain—Doxorubicin—thyroid cancer	0.00202	0.00202	CcSEcCtD
Letrozole—Pulmonary embolism—Doxorubicin—thyroid cancer	0.002	0.002	CcSEcCtD
Letrozole—Anorexia—Sorafenib—thyroid cancer	0.00198	0.00198	CcSEcCtD
Letrozole—Vomiting—Vandetanib—thyroid cancer	0.00196	0.00196	CcSEcCtD
Letrozole—Rash maculo-papular—Epirubicin—thyroid cancer	0.00196	0.00196	CcSEcCtD
Letrozole—Neoplasm—Epirubicin—thyroid cancer	0.00195	0.00195	CcSEcCtD
Letrozole—Rash—Vandetanib—thyroid cancer	0.00195	0.00195	CcSEcCtD
Letrozole—Dermatitis—Vandetanib—thyroid cancer	0.00194	0.00194	CcSEcCtD
Letrozole—Headache—Vandetanib—thyroid cancer	0.00193	0.00193	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Sorafenib—thyroid cancer	0.0019	0.0019	CcSEcCtD
Letrozole—Dyspnoea—Sorafenib—thyroid cancer	0.00186	0.00186	CcSEcCtD
Letrozole—Nausea—Vandetanib—thyroid cancer	0.00183	0.00183	CcSEcCtD
Letrozole—Dyspepsia—Sorafenib—thyroid cancer	0.00183	0.00183	CcSEcCtD
Letrozole—Phlebitis—Epirubicin—thyroid cancer	0.00182	0.00182	CcSEcCtD
Letrozole—Rash maculo-papular—Doxorubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Letrozole—Decreased appetite—Sorafenib—thyroid cancer	0.00181	0.00181	CcSEcCtD
Letrozole—Thrombophlebitis—Epirubicin—thyroid cancer	0.00181	0.00181	CcSEcCtD
Letrozole—Neoplasm—Doxorubicin—thyroid cancer	0.0018	0.0018	CcSEcCtD
Letrozole—Gastrointestinal disorder—Sorafenib—thyroid cancer	0.0018	0.0018	CcSEcCtD
Letrozole—Fatigue—Sorafenib—thyroid cancer	0.0018	0.0018	CcSEcCtD
Letrozole—Pain—Sorafenib—thyroid cancer	0.00178	0.00178	CcSEcCtD
Letrozole—Constipation—Sorafenib—thyroid cancer	0.00178	0.00178	CcSEcCtD
Letrozole—Gastrointestinal pain—Sorafenib—thyroid cancer	0.0017	0.0017	CcSEcCtD
Letrozole—Phlebitis—Doxorubicin—thyroid cancer	0.00168	0.00168	CcSEcCtD
Letrozole—Hot flush—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Letrozole—Thrombophlebitis—Doxorubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Letrozole—Increased appetite—Epirubicin—thyroid cancer	0.00167	0.00167	CcSEcCtD
Letrozole—Menopausal symptoms—Epirubicin—thyroid cancer	0.00166	0.00166	CcSEcCtD
Letrozole—Urticaria—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Letrozole—Abdominal pain—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Letrozole—Body temperature increased—Sorafenib—thyroid cancer	0.00165	0.00165	CcSEcCtD
Letrozole—Cardiac failure—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Letrozole—Cerebrovascular accident—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Letrozole—Lethargy—Epirubicin—thyroid cancer	0.0016	0.0016	CcSEcCtD
Letrozole—Pain in extremity—Epirubicin—thyroid cancer	0.00157	0.00157	CcSEcCtD
Letrozole—Hot flush—Doxorubicin—thyroid cancer	0.00155	0.00155	CcSEcCtD
Letrozole—Increased appetite—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Letrozole—Menopausal symptoms—Doxorubicin—thyroid cancer	0.00154	0.00154	CcSEcCtD
Letrozole—Asthenia—Sorafenib—thyroid cancer	0.00149	0.00149	CcSEcCtD
Letrozole—Cardiac failure—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Letrozole—Cerebrovascular accident—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Letrozole—Lethargy—Doxorubicin—thyroid cancer	0.00148	0.00148	CcSEcCtD
Letrozole—Pruritus—Sorafenib—thyroid cancer	0.00147	0.00147	CcSEcCtD
Letrozole—Pain in extremity—Doxorubicin—thyroid cancer	0.00145	0.00145	CcSEcCtD
Letrozole—Dry skin—Epirubicin—thyroid cancer	0.00144	0.00144	CcSEcCtD
Letrozole—Diarrhoea—Sorafenib—thyroid cancer	0.00142	0.00142	CcSEcCtD
Letrozole—Breast disorder—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Epirubicin—thyroid cancer	0.00141	0.00141	CcSEcCtD
Letrozole—Dizziness—Sorafenib—thyroid cancer	0.00138	0.00138	CcSEcCtD
Letrozole—Influenza—Epirubicin—thyroid cancer	0.00135	0.00135	CcSEcCtD
Letrozole—Dry skin—Doxorubicin—thyroid cancer	0.00133	0.00133	CcSEcCtD
Letrozole—Vomiting—Sorafenib—thyroid cancer	0.00132	0.00132	CcSEcCtD
Letrozole—Angina pectoris—Epirubicin—thyroid cancer	0.00132	0.00132	CcSEcCtD
Letrozole—Rash—Sorafenib—thyroid cancer	0.00131	0.00131	CcSEcCtD
Letrozole—Dermatitis—Sorafenib—thyroid cancer	0.00131	0.00131	CcSEcCtD
Letrozole—Breast disorder—Doxorubicin—thyroid cancer	0.00131	0.00131	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Doxorubicin—thyroid cancer	0.0013	0.0013	CcSEcCtD
Letrozole—Headache—Sorafenib—thyroid cancer	0.0013	0.0013	CcSEcCtD
Letrozole—Influenza—Doxorubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Letrozole—Pollakiuria—Epirubicin—thyroid cancer	0.00125	0.00125	CcSEcCtD
Letrozole—Nausea—Sorafenib—thyroid cancer	0.00124	0.00124	CcSEcCtD
Letrozole—Weight increased—Epirubicin—thyroid cancer	0.00123	0.00123	CcSEcCtD
Letrozole—Weight decreased—Epirubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—thyroid cancer	0.00122	0.00122	CcSEcCtD
Letrozole—Infestation NOS—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Letrozole—Infestation—Epirubicin—thyroid cancer	0.00121	0.00121	CcSEcCtD
Letrozole—Stomatitis—Epirubicin—thyroid cancer	0.00118	0.00118	CcSEcCtD
Letrozole—Urinary tract infection—Epirubicin—thyroid cancer	0.00117	0.00117	CcSEcCtD
Letrozole—Sweating—Epirubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—thyroid cancer	0.00116	0.00116	CcSEcCtD
Letrozole—Hepatobiliary disease—Epirubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—thyroid cancer	0.00114	0.00114	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—thyroid cancer	0.00113	0.00113	CcSEcCtD
Letrozole—Infestation—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—thyroid cancer	0.00112	0.00112	CcSEcCtD
Letrozole—Haemoglobin—Epirubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—thyroid cancer	0.00109	0.00109	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Letrozole—Hypoaesthesia—Epirubicin—thyroid cancer	0.00108	0.00108	CcSEcCtD
Letrozole—Sweating—Doxorubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Letrozole—Oedema peripheral—Epirubicin—thyroid cancer	0.00107	0.00107	CcSEcCtD
Letrozole—Connective tissue disorder—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—thyroid cancer	0.00106	0.00106	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—thyroid cancer	0.00102	0.00102	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Letrozole—Flushing—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—thyroid cancer	0.00101	0.00101	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—thyroid cancer	0.001	0.001	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—thyroid cancer	0.000997	0.000997	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—thyroid cancer	0.00099	0.00099	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—thyroid cancer	0.000987	0.000987	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—thyroid cancer	0.000985	0.000985	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—thyroid cancer	0.000983	0.000983	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—thyroid cancer	0.000982	0.000982	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—thyroid cancer	0.000976	0.000976	CcSEcCtD
Letrozole—Alopecia—Epirubicin—thyroid cancer	0.000957	0.000957	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—thyroid cancer	0.000949	0.000949	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—thyroid cancer	0.000948	0.000948	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—thyroid cancer	0.000943	0.000943	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—thyroid cancer	0.000937	0.000937	CcSEcCtD
Letrozole—Flushing—Doxorubicin—thyroid cancer	0.00093	0.00093	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—thyroid cancer	0.00093	0.00093	CcSEcCtD
Letrozole—Tension—Epirubicin—thyroid cancer	0.000925	0.000925	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—thyroid cancer	0.000923	0.000923	CcSEcCtD
Letrozole—Nervousness—Epirubicin—thyroid cancer	0.000916	0.000916	CcSEcCtD
Letrozole—Back pain—Epirubicin—thyroid cancer	0.000912	0.000912	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—thyroid cancer	0.000909	0.000909	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—thyroid cancer	0.000903	0.000903	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—thyroid cancer	0.000889	0.000889	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—thyroid cancer	0.000886	0.000886	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—thyroid cancer	0.000878	0.000878	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—thyroid cancer	0.000875	0.000875	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—thyroid cancer	0.000873	0.000873	CcSEcCtD
Letrozole—Tension—Doxorubicin—thyroid cancer	0.000856	0.000856	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—thyroid cancer	0.000854	0.000854	CcSEcCtD
Letrozole—Malaise—Epirubicin—thyroid cancer	0.00085	0.00085	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—thyroid cancer	0.000847	0.000847	CcSEcCtD
Letrozole—Vertigo—Epirubicin—thyroid cancer	0.000847	0.000847	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—thyroid cancer	0.000844	0.000844	CcSEcCtD
Letrozole—Back pain—Doxorubicin—thyroid cancer	0.000844	0.000844	CcSEcCtD
Letrozole—Palpitations—Epirubicin—thyroid cancer	0.000833	0.000833	CcSEcCtD
Letrozole—Cough—Epirubicin—thyroid cancer	0.000823	0.000823	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—thyroid cancer	0.000822	0.000822	CcSEcCtD
Letrozole—Hypertension—Epirubicin—thyroid cancer	0.000814	0.000814	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—thyroid cancer	0.00081	0.00081	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—thyroid cancer	0.000803	0.000803	CcSEcCtD
Letrozole—Myalgia—Epirubicin—thyroid cancer	0.000803	0.000803	CcSEcCtD
Letrozole—Chest pain—Epirubicin—thyroid cancer	0.000803	0.000803	CcSEcCtD
Letrozole—Anxiety—Epirubicin—thyroid cancer	0.0008	0.0008	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—thyroid cancer	0.000797	0.000797	CcSEcCtD
Letrozole—Discomfort—Epirubicin—thyroid cancer	0.000793	0.000793	CcSEcCtD
Letrozole—Malaise—Doxorubicin—thyroid cancer	0.000787	0.000787	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—thyroid cancer	0.000785	0.000785	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—thyroid cancer	0.000784	0.000784	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—thyroid cancer	0.000781	0.000781	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—thyroid cancer	0.000771	0.000771	CcSEcCtD
Letrozole—Oedema—Epirubicin—thyroid cancer	0.00077	0.00077	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—thyroid cancer	0.00077	0.00077	CcSEcCtD
Letrozole—Infection—Epirubicin—thyroid cancer	0.000765	0.000765	CcSEcCtD
Letrozole—Cough—Doxorubicin—thyroid cancer	0.000761	0.000761	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—thyroid cancer	0.000755	0.000755	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—thyroid cancer	0.000753	0.000753	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—thyroid cancer	0.000751	0.000751	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—thyroid cancer	0.000748	0.000748	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—thyroid cancer	0.000744	0.000744	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—thyroid cancer	0.000743	0.000743	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—thyroid cancer	0.000743	0.000743	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—thyroid cancer	0.000743	0.000743	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—thyroid cancer	0.00074	0.00074	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—thyroid cancer	0.000738	0.000738	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—thyroid cancer	0.000734	0.000734	CcSEcCtD
Letrozole—Anorexia—Epirubicin—thyroid cancer	0.000734	0.000734	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—thyroid cancer	0.000726	0.000726	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—thyroid cancer	0.000712	0.000712	CcSEcCtD
Letrozole—Oedema—Doxorubicin—thyroid cancer	0.000712	0.000712	CcSEcCtD
Letrozole—Infection—Doxorubicin—thyroid cancer	0.000707	0.000707	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—thyroid cancer	0.000701	0.000701	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—thyroid cancer	0.000698	0.000698	CcSEcCtD
Letrozole—Insomnia—Epirubicin—thyroid cancer	0.000696	0.000696	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—thyroid cancer	0.000695	0.000695	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—thyroid cancer	0.000692	0.000692	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—thyroid cancer	0.000691	0.000691	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—thyroid cancer	0.000688	0.000688	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—thyroid cancer	0.000686	0.000686	CcSEcCtD
Letrozole—Somnolence—Epirubicin—thyroid cancer	0.000684	0.000684	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—thyroid cancer	0.000679	0.000679	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—thyroid cancer	0.000677	0.000677	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—thyroid cancer	0.000669	0.000669	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—thyroid cancer	0.000664	0.000664	CcSEcCtD
Letrozole—Fatigue—Epirubicin—thyroid cancer	0.000664	0.000664	CcSEcCtD
Letrozole—Pain—Epirubicin—thyroid cancer	0.000658	0.000658	CcSEcCtD
Letrozole—Constipation—Epirubicin—thyroid cancer	0.000658	0.000658	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—thyroid cancer	0.000649	0.000649	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—thyroid cancer	0.000644	0.000644	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—thyroid cancer	0.000639	0.000639	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—thyroid cancer	0.000635	0.000635	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—thyroid cancer	0.000634	0.000634	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—thyroid cancer	0.000633	0.000633	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—thyroid cancer	0.000629	0.000629	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—thyroid cancer	0.000627	0.000627	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—thyroid cancer	0.000619	0.000619	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—thyroid cancer	0.000615	0.000615	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—thyroid cancer	0.000614	0.000614	CcSEcCtD
Letrozole—Urticaria—Epirubicin—thyroid cancer	0.000611	0.000611	CcSEcCtD
Letrozole—Pain—Doxorubicin—thyroid cancer	0.000609	0.000609	CcSEcCtD
Letrozole—Constipation—Doxorubicin—thyroid cancer	0.000609	0.000609	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—thyroid cancer	0.000608	0.000608	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—thyroid cancer	0.000608	0.000608	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—thyroid cancer	0.000587	0.000587	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—thyroid cancer	0.000582	0.000582	CcSEcCtD
Letrozole—Urticaria—Doxorubicin—thyroid cancer	0.000566	0.000566	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—thyroid cancer	0.000563	0.000563	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—thyroid cancer	0.000563	0.000563	CcSEcCtD
Letrozole—Asthenia—Epirubicin—thyroid cancer	0.000552	0.000552	CcSEcCtD
Letrozole—Pruritus—Epirubicin—thyroid cancer	0.000544	0.000544	CcSEcCtD
Letrozole—Diarrhoea—Epirubicin—thyroid cancer	0.000527	0.000527	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—thyroid cancer	0.000511	0.000511	CcSEcCtD
Letrozole—Dizziness—Epirubicin—thyroid cancer	0.000509	0.000509	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—thyroid cancer	0.000504	0.000504	CcSEcCtD
Letrozole—Vomiting—Epirubicin—thyroid cancer	0.000489	0.000489	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—thyroid cancer	0.000487	0.000487	CcSEcCtD
Letrozole—Rash—Epirubicin—thyroid cancer	0.000485	0.000485	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—thyroid cancer	0.000485	0.000485	CcSEcCtD
Letrozole—Headache—Epirubicin—thyroid cancer	0.000482	0.000482	CcSEcCtD
Letrozole—Dizziness—Doxorubicin—thyroid cancer	0.000471	0.000471	CcSEcCtD
Letrozole—Nausea—Epirubicin—thyroid cancer	0.000457	0.000457	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—thyroid cancer	0.000453	0.000453	CcSEcCtD
Letrozole—Rash—Doxorubicin—thyroid cancer	0.000449	0.000449	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—thyroid cancer	0.000449	0.000449	CcSEcCtD
Letrozole—Headache—Doxorubicin—thyroid cancer	0.000446	0.000446	CcSEcCtD
Letrozole—Nausea—Doxorubicin—thyroid cancer	0.000423	0.000423	CcSEcCtD
